Literature DB >> 30319185

3,3'-Diindolylmethane Encapsulated Chitosan Nanoparticles Accelerates Inflammatory Markers, ER/PR, Glycoprotein and Mast Cells Population During Chemical Carcinogen Induced Mammary Cancer in Rats.

Stainsloss Isabella1, Sankaran Mirunalini1, Kannaiyan Pandiyan2.   

Abstract

The present study aimed to investigate the effect of 3,3'-diindolylmethane (DIM) on inflammatory markers, estrogen receptors (ER), progesterone receptors (PR), level of glycoprotein and the mast cell population in 7,12-dimethylbenz (a) anthracene (DMBA) 25 mg/kg b.wt. induced rat mammary carcinogenesis. After 8 weeks of tumor formation, rats had access to an oral administrated with DIM 10 mg/kg b.wt. and DIM@CS-NP 0.5 mg/kg body weight respectively for 8 weeks. The oral administration of DIM@CS-NP 0.5 mg/kg b.wt. suppressed the Cox-2, NF-κB and TNF-α protein expression on DMBA induced rats compared to DIM 10 mg/kg b.wt. The ER/PR levels were increased on DMBA induced rats, treated with DIM@CS-NP 0.5 mg/kg b.wt. reduced ER/PR level as well as glycoprotein and mast cell population than DIM 10 mg/kg b.wt. The result shows that, DIM@CS-NP 0.5 mg/kg b.wt. has the potentially inhibit abnormal levels of inflammatory markers, ER, PR, levels of glycoprotein and mast cell population compared to DIM 10 mg/kg b.wt.

Entities:  

Keywords:  Breast cancer; DIM@CS-NP; Glycoprotein; NF-κB; TNF-α

Year:  2017        PMID: 30319185      PMCID: PMC6170234          DOI: 10.1007/s12291-017-0701-2

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  23 in total

Review 1.  Apoptosis in mammary gland and cancer.

Authors:  R Kumar; R K Vadlamudi; L Adam
Journal:  Endocr Relat Cancer       Date:  2000-12       Impact factor: 5.678

2.  Role of cholesterol in the development and progression of breast cancer.

Authors:  Gemma Llaverias; Christiane Danilo; Isabelle Mercier; Kristin Daumer; Franco Capozza; Terence M Williams; Federica Sotgia; Michael P Lisanti; Philippe G Frank
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

3.  CTGF inhibits cell motility and COX-2 expression in oral cancer cells.

Authors:  Jing-Yuan Chuang; Wan-Yu Yang; Chih-Ho Lai; Chia-Der Lin; Ming-Hsui Tsai; Chih-Hsin Tang
Journal:  Int Immunopharmacol       Date:  2011-02-23       Impact factor: 4.932

4.  Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells.

Authors:  N T Telang; A Suto; G Y Wong; M P Osborne; H L Bradlow
Journal:  J Natl Cancer Inst       Date:  1992-04-15       Impact factor: 13.506

Review 5.  Fruit, vegetables, and the prevention of cancer: research challenges.

Authors:  Norman J Temple; Kerri Kaiser Gladwin
Journal:  Nutrition       Date:  2003-05       Impact factor: 4.008

6.  Induction of growth arrest and apoptosis in human breast cancer cells by 3,3-diindolylmethane is associated with induction and nuclear localization of p27kip.

Authors:  Zhiwei Wang; Bennett W Yu; K M Wahidur Rahman; Fakhara Ahmad; Fazlul H Sarkar
Journal:  Mol Cancer Ther       Date:  2008-02       Impact factor: 6.261

7.  Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles.

Authors:  Yong Hu; Xiqun Jiang; Yin Ding; Haixiong Ge; Yuyan Yuan; Changzheng Yang
Journal:  Biomaterials       Date:  2002-08       Impact factor: 12.479

8.  Anticancer activity of fungal taxol derived from Botryodiplodia theobromae Pat., an endophytic fungus, against 7, 12 dimethyl benz(a)anthracene (DMBA)-induced mammary gland carcinogenesis in Sprague Dawley rats.

Authors:  M Pandi; R Manikandan; J Muthumary
Journal:  Biomed Pharmacother       Date:  2009-09-03       Impact factor: 6.529

Review 9.  Cyclooxygenase 2: a molecular target for cancer prevention and treatment.

Authors:  Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Trends Pharmacol Sci       Date:  2003-02       Impact factor: 14.819

10.  Prognostic significance of periodic acid-Schiff-positive patterns in primary breast cancer and its lymph node metastases.

Authors:  Jeroen T Buijs; Anne-Marie Cleton; Vincent T H B M Smit; Clemens W G M Löwik; Socrates E Papapoulos; Gabri van der Pluijm
Journal:  Breast Cancer Res Treat       Date:  2004-03       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.